Join us June 13 for a Journal Club event!
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌
Problems viewing this email?
A header image that says "Health Affairs Sunday."
Sunday, June 11, 2023 | The Latest Research, Commentary, And News From Health Affairs
Dear John,

To celebrate Health Affairs Insider's first anniversary, new Insider or Unlimited members can enjoy $40 off to celebrate Health Affairs Insider's first anniversary!

Use discount code InsiderAtOne.

Medicaid, Drug Pricing, Aging & More
This week, we released a new issue!

The June issue of Health Affairs explores a wide range of topics, including children’s Medicaid coverage, competition in the biosimilars market, sites of care for people with Alzheimer’s disease, and more.

We are pleased to include for the first time the official projections of nonelderly
health insurance coverage for 2023–33 prepared by the Congressional Budget Office Coverage Team of Caroline Hanson and colleagues.

One of the areas of focus in this issue was
drug pricing.

Through the Medicaid Drug Rebate Program, state Medicaid programs receive mandatory rebates when prices rise faster than inflation.

Congress expanded that program in 2017 to include generic drugs.

Benjamin Rome and coauthors find that between 2017 and
2020, inflationary rebates "offset an estimated 2–12 percent of the $54 billion total Medicaid generic drug spending."

Alice Chen and coauthors compare prices and market-share dominance of the cancer drug trastuzumab (Herceptin) and five biosimilars.

They find that after
the introduction of biosimilars in 2019– 20, Herceptin accounted for 45.3 percent of Medicare trastuzumab claims, whereas Kanjinti (a biosimilar) accounted for 39.6 percent of claims.

Check out the table of contents to take a look at all of the articles in this month's edition.

 
 

LGBTQ+ Health Care Policies: Two Steps Forward, Two Steps Backward?

In honor of Pride Month, Health Affairs' Kathleen Haddad and Michael Gerber discuss the state of health policy related to the LBGTQ+ community. They discuss the impact of state policies on the community, the burgeoning data on gender, and more.



Kelsey Owsley on 340B's Effect on Oncology Services


Health Affairs' Alan Weil interviews Kelsey Owsley from the University of Arkansas for Medical Sciences on her new paper assessing whether the 340B drug pricing program leads to increase in oncology services in rural hospitals.
 
 
 
About Health Affairs

Health Affairs is the leading peer-reviewed journal at the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online. Late-breaking content is also found through healthaffairs.org, Health Affairs Today, and Health Affairs Sunday Update.  

Project HOPE is a global health and humanitarian relief organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.
Health Affairs, 1220 19th Street, NW, Suite 800, Washington, DC 20036, United States

Privacy Policy

To unsubscribe from this email, update your email preferences here
.
Facebook
 
Twitter
 
Linkedin
 
Youtube
 
Email